What Can IBD Specialists Learn from IL-23 Trials in Dermatology?

por Valenti, Mario, Narcisi, Alessandra, Pavia, Giulia, Gargiulo, Luigi, Costanzo, Antonio
Publicado 2022

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report

por Valenti, Mario, Gargiulo, Luigi, Ibba, Luciano, Pavia, Giulia, Narcisi, Alessandra, Costanzo, Antonio
Publicado 2022

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab

por Gargiulo, Luigi, Toso, Francesco, Ibba, Luciano, Valenti, Mario, Costanzo, Antonio, Narcisi, Alessandra
Publicado 2023

Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study

por Gargiulo, Luigi, Ibba, Luciano, Cortese, Andrea, Avagliano, Jessica, Valenti, Mario, Costanzo, Antonio, Narcisi, Alessandra
Publicado 2023

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

por Gargiulo, Luigi, Pavia, Giulia, Valenti, Mario, Lleo de Nalda, Ana, Perugini, Chiara, Costanzo, Antonio, Narcisi, Alessandra
Publicado 2022

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

por Cortese, Andrea, Gargiulo, Luigi, Ibba, Luciano, Fiorillo, Giovanni, Toso, Francesco, Vignoli, Carlo Alberto, Narcisi, Alessandra, Costanzo, Antonio, Valenti, Mario
Publicado 2023

Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report

por Facheris, Paola, De Santis, Maria, Gargiulo, Luigi, Pavia, Giulia, Valenti, Mario, Manara, Sofia, Borroni, Riccardo G., Costanzo, Antonio, Narcisi, Alessandra
Publicado 2020

Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant

por Kamath, Arun T., Rochat, Anne-Françoise, Valenti, Mario P., Agger, Else Marie, Lingnau, Karen, Andersen, Peter, Lambert, Paul-Henri, Siegrist, Claire-Anne
Publicado 2008

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study

por Gargiulo, Luigi, Ibba, Luciano, Pavia, Giulia, Vignoli, Carlo Alberto, Piscazzi, Francesco, Valenti, Mario, Sanna, Federica, Perugini, Chiara, Avagliano, Jessica, Costanzo, Antonio, Narcisi, Alessandra
Publicado 2022

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

por BORRONI, Riccardo G., MALAGOLI, Piergiorgio, GARGIULO, Luigi, VALENTI, Mario, PAVIA, Giulia, FACHERIS, Paola, MORENGHI, Emanuela, DI CORTERANZO, Isotta Giunipero, NARCISI, Alessandra, ORTONCELLI, Michela, DAPAVO, Paolo, COSTANZO, Antonio
Publicado 2021

Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy

por Borroni, Riccardo G., Panasiti, Vincenzo, Valenti, Mario, Gargiulo, Luigi, Perrone, Giuseppe, Dall’Alba, Roberta, Fava, Clarissa, Sacrini, Francesco, Mancini, Luca L., Manara, Sofia A. A. M., Morenghi, Emanuela, Costanzo, Antonio
Publicado 2023

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)

por Narcisi, Alessandra, Valenti, Mario, Gargiulo, Luigi, Ibba, Luciano, Amoruso, Fabrizio, Argenziano, Giuseppe, Bardazzi, Federico, Burlando, Martina, Carrera, Carlo Giovanni, Damiani, Giovanni, Dapavo, Paolo, Dini, Valentina, Franchi, Chiara, Girolomoni, Giampiero, Guarneri, Claudio, Loconsole, Francesco, Sampogna, Francesca, Travaglini, Massimo, Malagoli, Piergiorgio, Costanzo, Antonio
Publicado 2022